€14.35
1.03% today
Xetra, Feb 28, 04:47 pm CET
ISIN
DE000A0STSQ8
Symbol
M12

M1 Kliniken Stock price

€14.50
-0.50 3.33% 1M
-0.20 1.36% 6M
-2.10 12.65% YTD
+1.75 13.73% 1Y
+7.28 100.83% 3Y
+0.00 0.00% 5Y
+9.50 190.06% 10Y
Xetra, Closing price Thu, Feb 27 2025
+0.10 0.69%
ISIN
DE000A0STSQ8
Symbol
M12
Sector

Key metrics

Market capitalization €277.33m
Enterprise Value €315.16m
P/E (TTM) P/E ratio 16.55
EV/FCF (TTM) EV/FCF 15.37
EV/Sales (TTM) EV/Sales 0.95
P/S ratio (TTM) P/S ratio 0.83
P/B ratio (TTM) P/B ratio 2.54
Dividend yield 3.45%
Last dividend (FY23) €0.50
Revenue growth (TTM) Revenue growth 12.05%
Revenue (TTM) Revenue €333.27m
EBIT (operating result TTM) EBIT €22.89m
Free Cash Flow (TTM) Free Cash Flow €20.50m
EPS (TTM) EPS €0.88
P/E forward 18.35
P/S forward 0.81
EV/Sales forward 0.92
Show more

Is M1 Kliniken a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

M1 Kliniken Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a M1 Kliniken forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a M1 Kliniken forecast:

Buy
100%

Financial data from M1 Kliniken

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
333 333
12% 12%
100%
- Direct Costs 298 298
10% 10%
90%
35 35
39% 39%
10%
- Selling and Administrative Expenses 6.81 6.81
4% 4%
2%
- Research and Development Expense - -
-
-
28 28
56% 56%
8%
- Depreciation and Amortization 5.14 5.14
12% 12%
2%
EBIT (Operating Income) EBIT 23 23
88% 88%
7%
Net Profit 17 17
164% 164%
5%

In millions EUR.

Don't miss a Thing! We will send you all news about M1 Kliniken directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. It operates through the Beauty and Trade segments. The Beauty segment focuses on medical-aesthetic beauty treatments and operations as well as the operation and provision of medical infrastructures for partner companies. The Trade segment sells pharmaceuticals and medical products in the cost-intensive therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was founded in 2007 and is headquartered in Berlin, Germany.

Head office Germany
CEO Patrick Brenske
Founded 2007
Website www.m1-kliniken.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today